These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8066489)

  • 1. Cost utility analysis: what should be measured?
    Richardson J
    Soc Sci Med; 1994 Jul; 39(1):7-21. PubMed ID: 8066489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods for assessing relative importance in preference based outcome measures.
    Kaplan RM; Feeny D; Revicki DA
    Qual Life Res; 1993 Dec; 2(6):467-75. PubMed ID: 8161981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The trade-off between severity of illness and treatment effect in cost-value analysis of health care.
    Nord E
    Health Policy; 1993 Aug; 24(3):227-38. PubMed ID: 10128127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preference-based measures in economic evaluation in health care.
    Neumann PJ; Goldie SJ; Weinstein MC
    Annu Rev Public Health; 2000; 21():587-611. PubMed ID: 10884966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A psychometric analysis of the measurement level of the rating scale, time trade-off, and standard gamble.
    Cook KF; Ashton CM; Byrne MM; Brody B; Geraci J; Giesler RB; Hanita M; Souchek J; Wray NP
    Soc Sci Med; 2001 Nov; 53(10):1275-85. PubMed ID: 11676400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome measurement in economic evaluation.
    Johannesson M; Jönsson B; Karlsson G
    Health Econ; 1996; 5(4):279-96. PubMed ID: 8880165
    [No Abstract]   [Full Text] [Related]  

  • 8. A new and more robust test of QALYs.
    Doctor JN; Bleichrodt H; Miyamoto J; Temkin NR; Dikmen S
    J Health Econ; 2004 Mar; 23(2):353-67. PubMed ID: 15019761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of health state utilities for economic appraisal.
    Torrance GW
    J Health Econ; 1986 Mar; 5(1):1-30. PubMed ID: 10311607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferences for health outcomes and cost-utility analysis.
    Torrance GW
    Am J Manag Care; 1997 May; 3 Suppl():S8-20. PubMed ID: 10180342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The validity of the MIMIC (Multiple Indicators/MultIple Causes) health index--some empirical evidence.
    Leu RE; Gerfin M; Spycher S
    Dev Health Econ Public Policy; 1992; 1():109-42. PubMed ID: 10151742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HYE (healthy years equivalent) and TTO (time trade-off): what is the difference?
    Morrison GC
    J Health Econ; 1997 Oct; 16(5):563-78. PubMed ID: 10175631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should "standard gamble" and "'time trade off" utility measurement be used more in mental health research?
    Flood C
    J Ment Health Policy Econ; 2010 Jun; 13(2):65-72. PubMed ID: 20919593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trying to do better than average: a commentary on 'statistical inference for cost-effectiveness ratios'.
    Briggs A; Fenn P
    Health Econ; 1997; 6(5):491-5. PubMed ID: 9353649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the performance of utility techniques in the absence of a gold standard.
    Giesler RB; Ashton CM; Brody B; Byrne MM; Cook K; Geraci JM; Hanita M; Souchek J; Wray NP
    Med Care; 1999 Jun; 37(6):580-8. PubMed ID: 10386570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economics, health and health economics: HYEs (healthy-years equivalent) versus QALYs (quality-adjusted live-year).
    Gafni A; Birch S; Mehrez A
    J Health Econ; 1993 Oct; 12(3):325-39. PubMed ID: 10129840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling programme costs in economic evaluation.
    Fenn P; McGuire A; Backhouse M; Jones D
    J Health Econ; 1996 Feb; 15(1):115-25. PubMed ID: 10157425
    [No Abstract]   [Full Text] [Related]  

  • 18. Incorporating feelings related to the uncertainty about future health in utility measurement.
    Gandjour A
    Health Econ; 2008 Oct; 17(10):1207-13. PubMed ID: 18074407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discounting in the economic evaluation of health care interventions.
    Krahn M; Gafni A
    Med Care; 1993 May; 31(5):403-18. PubMed ID: 8501989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Explaining distortions in utility elicitation through the rank-dependent model for risky choices.
    Wakker P; Stiggelbout A
    Med Decis Making; 1995; 15(2):180-6. PubMed ID: 7783579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.